Journal of Medicinal Chemistry · 1992 · 75 citations · 0 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySynthetic Medicinal ChemistryBioactive Small MoleculesDiabetes ManagementHeterocyclic ChemistryInsulin ResistanceObesity PharmacotherapyStructure-activity Relationship AnalysisAntidiabetic Drug TherapyBlood Glucose RegulationMedicinal HeterocyclesOxadiazole ChemistryOxazole ChemistryOxazole SynthesisThiadiazole ChemistryThiazole Chemistry
A new series of thiazolidine-2,4-diones was obtained by replacing the ether function of englitazone with various functional groups, i.e., a ketone, alcohol, or olefin moiety. These compounds lower blood glucose levels in the genetically obese and insulin-resistant ob/ob mouse. Appending an oxazole-based group at the terminus of the chain provided highly potent compounds.